LASER, NCT06485674: Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus |
|
|
| Recruiting | N/A | 478 | Canada | | AstraZeneca, IQVIA Pvt. Ltd, University Health Network, Toronto | Long-Term Organ Damage in Adult Patients With Active Systemic Lupus Erythematosus | 05/25 | 05/25 | | |